Non target screening (NTS) is a cutting‑edge analytical approach that examines environmental and other samples without a predefined list of chemicals, allowing to detect unknown substances, trace emission sources and generate early‑warning signals for emerging pollutants. The method has matured and national databases emerge for retrospective screening and long‑term storage of NTS results. A recent workshop focused on discussing requirements and use cases for these data portals to facilitate regulatory uptake of these valuable data. EURL ECVAM’s Stephanie Bopp contributed by sharing experience from the IPCHEM monitoring data platform, highlighting the need for harmonised data formats and vocabularies, and outlining possible links to the future Common Data Platform on Chemicals.
News
EURL ECVAM recently participated in the 3D Cell Culture Summit, a key event in the field of alternative methods to animal testing. The summit brought together experts from industry, academia, and regulatory agencies to discuss the latest developments and advancements in 3D cell culture technology. EURL ECVAM's Maurice Whelan gave a keynote presentation that gave an EU perspective on how to address the challenges of translating in vitro biotechnologies towards regulatory and commercial applications. Our involvement in this event provided a valuable opportunity to get updated on the exciting progress being made in India and to identify avenues to build further cooperation.
The impact of chemical exposures on infectious diseases in the context of One Health
Events
EURL ECVAM will showcase the Student Ambassador Project and immersive Virtual Reality Lab experience at the MIND Social Innovation Campus in Milan which brings together science students, innovators, enterprises, academia, and research organisations.
EURL ECVAM will participate at the Modeling Life 2026 conference in Rome giving a presentation on: “Developing standards for emerging human-based technologies – the role of the European Commission”.
3DCC 2026 will feature focused scientific tracks on advances in 3D Cell Culture and Biofabrication, organoids and Organ-on-Chip Technologies, AI/ML and In-Silico Tools for Predictive Toxicology, Regulatory Science and Roadmaps for New Approach Methodologies (NAMs), Tissue Engineering and Regenerative Medicine.